From: Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease
Groups | Baseline (n; median [IQR]) | Follow-up (n; median [IQR]) | P-value |
---|---|---|---|
Control | 21; 6380.5 [4462.49–7656.29] | 18; 5152.05 [4681.11–6713.43] | NS |
Stage B1 | 39; 5140.91 [4094.13–7047.52] | 32; 5851.08 [4033.94–7557.08] | NS |
Stage B2 | 9; 4791.34 [4334.51–4969.2] | 12; 5352.87 [4261.51–8612.47] | NS |
Stage C | 14; 6556.58 [4713.07–8767.38] | 7; 5056.82 [4256.65–7119.38] | NS |